1. Big opportunities for small molecules in immuno-oncology;Adams;Nature Reviews Drug Discovery,2015
2. COVID-19 and antimicrobial resistance: A review;Adebisi;Infectious Diseases: Research and Treatment,2021
3. The development of preprints during the COVID-19 pandemic;Älgå;Journal of Internal Medicine,2021
4. Repetitive flaws. Strict guidelines to improve the reproducibility of experiments are a welcome move;Anonymous;Nature,2016
5. We have achieved peak biotech formation. It’s time for ‘musical chairs;Armstrong,2022